|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
High valuations, margin debt and the ARK effect could lead to more pain for some names. But the selloff could also create buying opportunities in other tech companies.
Pockets of speculative action keep shifting as the market undergoes some much-need corrective action.
Georgia's election results have given the industry a big green light, meaning positive moves are expected out of cannabis stocks.
Two more major deals were announced on Tuesday.
Aphria investors will have a larger stake in the combined company post-merger.
APHA's strategy is to perfect operations in Canada so that they'll be ready when cannabis is legalized in the U.S.
Here are three names that should drag on as other financially strapped names risk going up in smoke.
Look for Aphria to remain a major player in the industry.
If you want to find cheap stocks with great potential to rebound in 2020, the best place to look is marijuana names.
This group appears oversold and downgrades of the big cannabis names may trigger a "buy the bad news" reaction.
A host of other cannabis-related stocks has sprouted up that appear better for investing.
After a 2018 high, marijuana stocks are gaining popularity again, but which ones are producing the most green for investors? Here are the charts.
Tilray will look to sustain a sanguine sentiment on cannabis stocks on Tuesday.
Aurora is trying to ride the momentum of Aphria's earnings report and jump in front of other potential strong reports.
The charts of the cannabis producer indicate that its shares have found a support level.
The company has spent a lot of time and money trying to meet the supply needs of the recreational cannabis market.
* The luminous path of marijuana legalization for both medical and recreational uses appears less clear these days Pedro: Hey, man, am I driving okay? Man Stoner: [looks around] I think we're parked, man.- Up In Smoke Pot stock Aprhia's (share price...
A pair of earnings report this week will shed light on the future direction of two fast-growing companies in very different fields.
Five top marijuana stocks and four CBD plays in this speculative space.
A huge week is coming up for these well-known stocks.
This quarter is a heavy test for Tilray because of the stock's lofty valuation.
This $12 billion industry could rise to around $630 billion over time, according to Seaport analysts.
And the winners so far outnumber the losers among the six stocks that include a cannabis company, a couple financial giants and two oil plays.
Right now they are speculative growth stocks through and through.
Without Apple doing so well Monday the indices would look much different.